Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)-Gene Rearrangements. (2021)
Attributed to:
Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.741413
PubMed Identifier: 34594227
Publication URI: http://europepmc.org/abstract/MED/34594227
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812